VEGF ‐B prevents chronic hyperglycemia‐induced retinal vascular leakage by regulating the CDC42 ‐ ZO1 / VE ‐cadherin pathway
The FASEB Journal · 2024
DOI: 10.1096/fj.202300987rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Yuxue Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Binzhou Medical University, Yantai, China. Hauptthemen laut MEDLINE: cdc42 GTP-Binding Protein, Cadherins, Diabetic Retinopathy, Hyperglycemia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Taishan Scholar Project of Shandong Province, | Youth Innovation Technology Project of Higher School in Shandong Province (Colleges and Universities Youth Innovation Technology Program of Shandong Province).
Abstract (Originalsprache)
Non‐proliferative diabetic retinopathy (NPDR) is the early stage of diabetic retinopathy (DR) and is a chronic oxidative stress‐related ocular disease. Few treatments are approved for early DR. This study aimed to investigate the pathogenic mechanisms underlying the retinal micro‐vasculopathy induced by diabetes and to explore an early potential for treating early DR in a mouse model. The mouse model of type 1 diabetes was established by intraperitoneal injection of streptozotocin (STZ, 180 mg/kg), which was used as the early DR model. The body weight and blood glucose mice were measured regularly; The retinal vascular leakage in the early DR mice was determined by whole‐mount staining; Label‐free quantitative proteomic analysis and bioinformatics were used to explore the target proteins and signaling pathways associated with the retinal tissues of early DR mice; To detect the effects of target protein on endothelial cell proliferation, migration, and tube formation, knockdown and overexpression of VEGF‐B were performed in human retinal vascular endothelial cells (HRECs); Western blotting was used to detect the expression of target proteins in vitro and in vivo; Meanwhile, the therapeutic effect of VEGF‐B on vascular leakage has also been evaluated in vitro and in vivo. The protein expressions of vascular endothelial growth factor (VEGF)‐B and the Rho GTPases family member CDC42 were reduced in the retinal tissues of early DR. VEGF‐B upregulated the expression of CDC42/ZO1/VE‐cadherin and prevented hyperglycemia‐induced vascular leakage in HRECs. Standard intravitreal VEGF‐B injections improved the retinal vascular leakage and neurovascular response in early DR mice. Our findings demonstrated, for the first time, that in diabetes, the retinal vessels are damaged due to decreased VEGF‐B expression through downregulation of CDC42/ZO1/VE‐cadherin expression. Therefore, VEGF‐B could be used as a novel therapy for early DR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Binzhou Medical University, Yantai, China.
- Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, Binzhou Medical University, Yantai, China.
- School of Clinical Medicine, Binzhou Medical University, Yantai, China.
ORCID-Profile: Yuxue Xu, Yue Peng, Xiaojun Wu, Feixue Ni, Daxi Sun, Pengfei Zhang, Yang Yang, Miao Yan, Jia Mi, Geng Tian
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Taishan Scholar Project of Shandong Province
- | Youth Innovation Technology Project of Higher School in Shandong Province (Colleges and Universities Youth Innovation Technology Program of Shandong Province)
- | Major Basic Research Project of Shandong Provincial Natural Science Foundation
- | Science Fund for Distinguished Young Scholars of Shandong Province ()
- | Youth Science Foundation project of Shandong Province Natural Science Foundation
- |Special Project of Central Government for Local Science and Technology Development of Shandong Province
- Yantai Science and Technology Innovation Development Plan Project (Yantai Science and Technology Bureau)
Zitieren
APA
Xu, Y., Peng, Y., Wu, X., Ni, F., Sun, D., Zhang, P., Yang, Y., Yan, M., Mi, J., & Tian, G. (2024). VEGF ‐B prevents chronic hyperglycemia‐induced retinal vascular leakage by regulating the CDC42 ‐ ZO1 / VE ‐cadherin pathway. The FASEB Journal. https://doi.org/10.1096/fj.202300987rr
Vancouver
Xu Y, Peng Y, Wu X, Ni F, Sun D, Zhang P, et al. VEGF ‐B prevents chronic hyperglycemia‐induced retinal vascular leakage by regulating the CDC42 ‐ ZO1 / VE ‐cadherin pathway. The FASEB Journal. 2024. doi:10.1096/fj.202300987rr
BibTeX
@article{Xu2024,
author = {Xu, Yuxue and Peng, Yue and Wu, Xiaojun and Ni, Feixue and Sun, Daxi and Zhang, Pengfei and Yang, Yang and Yan, Miao and Mi, Jia and Tian, Geng},
title = {VEGF ‐B prevents chronic hyperglycemia‐induced retinal vascular leakage by regulating the CDC42 ‐ ZO1 / VE ‐cadherin pathway},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202300987rr}
}
EUVIMED